| Latest | Forecast | |
|---|---|---|
| Div Yield | n/a | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | n/a |
| Latest | Forecast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Price / Revenue | n/a | n/a |
| Price / Book value | n/a |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (m) |
Pre-tax (m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|
| Scancell appoints interim CFO as it hunts for permanent successor Sharecast News | 02 Apr |
|---|---|
| FDA clears Scancell's application for phase three trial Sharecast News | 26 Jan |
| Scancell reports further data from DNA cancer immunotherapy trial Sharecast News | 09 Dec |